Edesa Biotech Inc. (EDSA)
NASDAQ: EDSA
· Real-Time Price · USD
2.03
-0.02 (-0.98%)
At close: Jun 30, 2025, 3:59 PM
1.97
-2.96%
After-hours: Jun 30, 2025, 07:47 PM EDT
Edesa Biotech Revenue Breakdown
| Period Ending | Sep 30, 2018 |
|---|---|
| Product Revenue | 211.85K |
| Product Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.15M | 878.87K | 900.53K | 1.04M | 998.74K | 1.11M | 1.42M | 1.04M | 952.39K | 1.02M | 1.04M | 1.25M | 1.53M | 1.21M | 1.36M | 1.61M | 1.54M | 1.23M | 853.89K | 733.08K | 1.11M | 681.71K | 798.3K | 817.93K | 1.33M | 882.8K | 653.74K | 651.17K | 773.99K | 678.48K | 630.84K | 635.72K | 746.36K | 932.07K | 727.6K | 720.42K | 765.07K | 1.11M | 881.53K | 618.18K | 785.68K |
| Selling, General, and Administrative Revenue Growth | +31.37% | -2.41% | -13.00% | +3.64% | -9.86% | -21.77% | +36.36% | +9.05% | -6.72% | -2.05% | -16.61% | -18.43% | +26.58% | -10.77% | -15.64% | +4.76% | +24.39% | +44.53% | +16.48% | -34.19% | +63.40% | -14.60% | -2.40% | -38.30% | +50.17% | +35.04% | +0.40% | -15.87% | +14.08% | +7.55% | -0.77% | -14.82% | -19.92% | +28.10% | +1.00% | -5.84% | -31.06% | +25.88% | +42.60% | -21.32% | n/a |
| Research and Development Revenue | 484.31K | 1.02M | 103.87K | 897.3K | 1.18M | 704.46K | 953.4K | 1.03M | 1.46M | 1.36M | 1.79M | 4.55M | 3.04M | 3.95M | 4.13M | 4.46M | 7.98M | 1.38M | 1.15M | 1.14M | 502.81K | 528K | 481.8K | 502.93K | 375.73K | 470.28K | 497.31K | 465.18K | 493.87K | 631.03K | 647K | 536.17K | 329.37K | 460.87K | 661.44K | 470.1K | 309.06K | 288.85K | 199.37K | 129.71K | 281.58K |
| Research and Development Revenue Growth | -52.51% | +881.85% | -88.42% | -23.72% | +66.98% | -26.11% | -7.04% | -29.66% | +7.43% | -24.34% | -60.55% | +49.45% | -22.99% | -4.28% | -7.54% | -44.02% | +478.07% | +19.47% | +0.95% | +127.49% | -4.77% | +9.59% | -4.20% | +33.85% | -20.10% | -5.44% | +6.91% | -5.81% | -21.74% | -2.47% | +20.67% | +62.79% | -28.53% | -30.32% | +40.70% | +52.10% | +7.00% | +44.88% | +53.71% | -53.94% | n/a |